Stock 8156 SINOPHARM TECH HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sinopharm Tech Holdings Limited

Equities

8156

KYG2159V1418

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:06 2024-04-30 am EDT 		5-day change 1st Jan Change
0.116 HKD +13.73% Intraday chart for Sinopharm Tech Holdings Limited +22.11% -12.12%
Feb. 29 Sinopharm Tech Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
2023 Sinopharm Tech Holdings Limited Announces Management Changes CI

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 2,106 1,048 823.6 1,189 544.5 64.29
Enterprise Value (EV) 1 2,231 1,178 967.6 1,344 596 62.52
P/E ratio -34.5 x -18.8 x -4.91 x -10.9 x -6.13 x -6.02 x
Yield - - - - - -
Capitalization / Revenue 83.1 x 24.1 x 4.96 x 15.3 x 13.3 x 1.5 x
EV / Revenue 88 x 27.1 x 5.83 x 17.3 x 14.5 x 1.46 x
EV / EBITDA -36 x -51.3 x -53 x -24.4 x -8.13 x -0.69 x
EV / FCF 40.8 x -14.7 x 218 x -52.2 x 20.8 x -3.01 x
FCF Yield 2.45% -6.82% 0.46% -1.92% 4.81% -33.2%
Price to Book -35.5 x 27.8 x -11.3 x -8.56 x -3.26 x -0.37 x
Nbr of stocks (in thousands) 131,634 164,354 171,589 176,159 181,508 183,693
Reference price 2 16.00 6.375 4.800 6.750 3.000 0.3500
Announcement Date 9/27/18 9/27/19 9/29/20 9/29/21 9/30/22 9/29/23
1HKD in Million2HKD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 25.35 43.5 165.9 77.81 40.98 42.84
EBITDA 1 -62.01 -22.95 -18.25 -55.14 -73.3 -90.13
EBIT 1 -74.77 -34.03 -25.95 -60.45 -74.62 -91.34
Operating Margin -294.98% -78.22% -15.64% -77.69% -182.06% -213.21%
Earnings before Tax (EBT) 1 -73.4 -47.94 -165.4 -111.1 -94.16 -11.41
Net income 1 -61.03 -46.8 -161.1 -106.3 -88 -10.64
Net margin -240.79% -107.57% -97.07% -136.66% -214.71% -24.83%
EPS 2 -0.4637 -0.3384 -0.9777 -0.6183 -0.4892 -0.0582
Free Cash Flow 1 54.74 -80.34 4.449 -25.76 28.69 -20.76
FCF margin 215.95% -184.68% 2.68% -33.1% 70% -48.47%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 9/27/18 9/27/19 9/29/20 9/29/21 9/30/22 9/29/23
1HKD in Million2HKD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 125 130 144 155 51.4 -
Net Cash position 1 - - - - - 1.78
Leverage (Debt/EBITDA) -2.013 x -5.687 x -7.889 x -2.808 x -0.7016 x -
Free Cash Flow 1 54.7 -80.3 4.45 -25.8 28.7 -20.8
ROE (net income / shareholders' equity) 290% 401% 907% 103% 59.7% 5.72%
ROA (Net income/ Total Assets) -30.2% -10.5% -7.78% -23.3% -43.8% -103%
Assets 1 202.2 444.7 2,070 456 200.8 10.28
Book Value Per Share 2 -0.4500 0.2300 -0.4300 -0.7900 -0.9200 -0.9400
Cash Flow per Share 2 0.0400 0.0400 0.0400 0.0400 0.0200 0.0100
Capex 1 0.46 - 23.4 10.1 0.12 -
Capex / Sales 1.8% - 14.09% 13% 0.3% -
Announcement Date 9/27/18 9/27/19 9/29/20 9/29/21 9/30/22 9/29/23
1HKD in Million2HKD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
SINOPHARM TECH HOLDINGS LIMITED Stock Sinopharm Tech Holdings Limited
-12.12% 2.72M
ABBOTT LABORATORIES Stock Abbott Laboratories
-3.72% 184B
MEDTRONIC PLC Stock Medtronic plc
-2.60% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.79% 67.78B
DEXCOM, INC. Stock DexCom, Inc.
+2.66% 50.66B
CENCORA, INC. Stock Cencora, Inc.
+16.39% 47.64B
HOYA CORPORATION Stock Hoya Corporation
+4.60% 41.12B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+1.38% 26.3B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+1.52% 26.04B
TERUMO CORPORATION Stock Terumo Corporation
+15.06% 25.4B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 8156 Stock
  4. Financials Sinopharm Tech Holdings Limited